Trial
NCT06560333
iSGLT2 Inhibitor and a iDPP -4 Inhibitor in Treatment of Type 2 Diabetes Mellitus in Patients Treated With Metformin (TRIAD)
Phase IIIWITHDRAWNOTHER/UNKNOWNConfidence: LOW
Sponsor
Eurofarma Laboratorios S.A.
Collaborators
—
Condition
Diabetes Mellitus, Type 2
Intervention
N0892
Why stopped
Strategic change in development priorities
Provenance
Dataset: 2026-07-02 • Source: ClinicalTrials.gov API v2 • Last update: 2025-12-18